Sumnlal'y The CD4 protein is expressed on a subset of human T lymphocytes that recognize antigen in the context of major histocompatibility complex (MHC) class II molecules. Using Chinese hamster ovary (CHO) cells expressing human CD4, we have previously demonstrated that the CD4 protein can mediate cell adhesion by direct interaction with MHC class II molecules. In T lymphocytes, CD4 can also function as a signaling molecule, presumably through its intracellular association with p56 ~k, a member of the src family of protein tyrosine kinases. In the present report, we show that p56 ~k can affect cell adhesion mediated by CD4 and MHC class II molecules. The expression of wild-type p56 ~k in CHO-CD4 cells augments the binding of MHC class II + B cells, whereas the expression of a mutant p56 ~ protein with elevated tyrosine kinase activity results in decreased binding of MHC class II + B cells. Using site-specific mutants of p56 ~k, we demonstrate that the both the enzymatic activity of p56 ~k and its association with CD4 are required for this effect on CD4/MHC class II adhesion. Further, the binding of MHC class II § B cells induces CD4 at the cell surface to become organized into structures resembling adherens-type junctions. Both wild-type and mutant forms of p56 ~k influence CD4-mediated adhesion by regulating the formation of these structures. The wild-type/ck protein enhances CD4/MHC class II adhesion by augmenting the formation of CD4-associated adherensjunctions whereas the elevated tyrosine kinase activity of the mutant p56 ~k decreases CD4-mediated cell adhesion by preventing the formation of these structures.
T heir cell-cell adhesion between T lymphocytes and their targets is an important prerequisite for efficient T cell stimulation. Initial interactions are mediated, in part, by members of the integrin family, including LFA-1, whose avidity for its counter-receptor on target cells can be upregulated through occupancy and signaling through the T cell receptor (reviewed in references 1, 2). The antigen-specific or/3 TCR recognizes foreign peptides displayed within the polymorphic antigen-binding cleft of MHC molecules (3) . Both CD4, on helper T cells, and CD8, on cytotoxic T cells, also play an important role in efficient T cell activation. The role of CD4 and CD8 as co-receptors important for antigen recognition and signaling has now become established (4), however, their importance as adhesion molecules remains controversial. We have previously demonstrated an interaction between human CD4 and MHC class II molecules that can mediate cell adhesion even in the absence of the TCR. (5, 6) . Similar studies have demonstrated an interaction between CD8 and MHC class I molecules (7) .
We have recently reported the characterization of CD4/class II adhesion using Chinese hamster ovary (CHO) t cells that 1 Abbreviation used in this paper: CHO, Chinese hamster ovary.
express the human CD4 protein on the cell surface (CHO-CD4 cells) (6) . Cell adhesion mediated by CD4 and MHC class II molecules is energy dependent and an intact cytoskeleton is required for the establishment and maintenance of stable cell conjugates. Analysis of the time course of cell binding revealed that the adhesion of radiolabeled MHC class II + Raji B cells was only detected after 2 h of incubation at 37~ yet cell conjugates remained stably associated for at least 6-8 h thereafter. We therefore questioned whether the observed time course for CD4/class II adhesion was physiologically relevant and sought to determine whether other T cell molecules, not present in CHO cells, might be involved in regulating adhesion/de-adhesion events.
p5C k, a lymphoid-specific tyrosine kinase, is associated intracellularly with CD4 (for review see references 8, 9) , suggesting that the lck protein might somehow play a regulatory role in adhesion through CD4. To test this hypothesis, we expressed either the wild-type (p56 ~k Y505) or a mutant form (p56 tck F505) of the Ick protein in CHO-CD4 cells. In resting T lymphocytes, the p56 ~k protein is phosphorylated at its carboxy-terminal tyrosine residue (10) (11) (12) and replacement of Y505 by phenylalanine (F505) results in an activated form of the protein that has been shown to cause oncogenic transformation when expressed in NIH 3T3 cells (13) . Upon T cell activation, it is thought that the CD45 phosphatase acts to dephosphorylate Y505, thereby activating the p56 ~k protein (14, 15) . Less well understood is the concomitant phosphorylation at Y394, that appears to be required for the kinase activity of the protein (16) (17) (18) . In vivo phosphorylation at this site can be measured in cells expressing the F505 form of the kinase, and to a lesser extent, upon antibody-mediated cross-linking of surface CD4 on cells expressing the wildtype kinase (12, 18, 19) . Antibody-mediated cross-linking of cell surface CD4 also results in the increased kinase activity of p56 ~k as measured by in vitro kinase assay (11) . Mutation of tyrosine to phenylalanine at position 394 prevents the activation of p56 ~k by CD4 cross-linking, implying that phosphorylation at this site provides a crucial positive regulatory signal.
In this report, we demonstrate that the expression of p56 t'k can dramatically alter cell adhesion mediated by CD4 and MHC class II molecules. Both the magnitude and time course of B cell adhesion to CHO-CD4 cells are affected by the presence of the p56 ~k protein and mutations in the Ick protein which affect its enzymatic activity alter its ability to enhance CD4/class II interactions. In the presence of the wild-type protein, cell surface CD4 protein becomes clustered at regions of cell-cell contact into structures resembling adherens-typejunctions (20) (21) (22) . Further, a large proportion of cell surface CD4 molecules are found to be associated with the actin cytoskeleton in the presence of the wild type protein. By contrast, adherens type junctions are not seen in the presence of the constitutively active F505 mutant of p56 ~k nor is the enhanced association of cell surface CD4 with the cytoskeleton. These observations suggest a mechanism by which the kk protein tethers CD4 molecules to the actin cytoskeleton thereby facilitating or stabilizing the clustering of CD4 molecules on the cell surface resulting in enhanced cell adhesion.
Materials and Methods
Cell Cuhure and Antibodies. B lymphoblastoid cell lines and hybridomas were cultured in RPMI (R.PMI 1640; GIBCO BILL, Gaithersburg, MD) supplemented with 10% FCS, 15 mM Hepes, 2 mM glutamine, penicillin, and streptomycin. CHO-DUKX II (CD4-) and CHO-CD4 ceUs were maintained in MEM-ct (GIBCO BILL) as described (6, 23) . Hybridomas secreting the mAbs TS1/18 (anti-LFAl~; CD18), TS1/22 (anti-LFAlot; CDlla; reference 24), OKT4 (mouse anti-human CD4), and GK1.5 (rat anti-L3T4) were obtained from the American Type Culture Collection (Kockville, MA) and used as culture supernatants or ascites fluid.
Transfection of p56 ~k. CHO-DUKX II or CHO-CD4 cells were co-transfected with 20/~g of the pNUT recombinant expression vector containing the murine wild-type (Y505) or mutant (F505) p56 ~ cDNAs (generously provided by K. Perlmutter, University of Washington, Seattle, WA) and 2.0/~g of the pCDneo plasmid using the BES-(N,N-bis-[2-hydroxyethyl]-2-aminoethanesulfonic acid; Calbiochem-Novabiochem Corp., La Jolla, CA) calcium phosphate transfection technique (6, 25) . After transfection, the cells were selected in media containing 150/zg/ml G418 (GIBCO BRL) and survivors were cloned by limiting dilution.
Northern Blot Analysis. Total cellular KNA was isolated by acid guanidium-phenol-chloroform extraction (26) . 15/zg of RNA was 1730 p56~k and CD4/MHC Class II size fractionated by formaldehyde-agarose gel electrophoresis (27) and blotted onto Hybond-N (Amersham Corp., Arlington Heights, IL) nylon membrane. Hybridization and washing was performed as described (28 Immunoblotting. 5 x 106 cells were washed with PBS and lysed in a solution containing 50 mM Tris-HC1, pH 8.0, 1% NP-40, 2 mM EDTA, 100/zM Na3VO4, 18 mg/ml PMSF, and 20 #g/ml leupeptin. Human CD4 was immunoprecipitated from CHO-CD4 cells using the OKT4 mAb and murine CD4 was immunoprecipitated from LSTRA cells using the GK1.5 mAb. SDS-PAGE and immunoblot analysis with anti-p56 ~ rabbit polyclonal antisera (kindly provided by Dr. Roger Perlmutter, University of Washington) was also performed as described (29) . Immunoreactive proteins were visualized using alkaline phosphatase-conjugated goat anti-rabbit IgG (GIBCO BRL) or lz~I-labeled protein A-Sepharose, as indicated.
Cell Adhesion Assay. 
Cytoskeletal Association Assay. The association between CD4
and the cytoskeleton was assessed as previously described (30 (13) . Subclones of transfected cells were isolated by limiting dilution. The presence of p56 ~ was confirmed by Northern blot analysis and immunoblotting of CD4 immunoprecipitates with p56 ~k antisera ( Fig. 1 ). In addition, both wild-type and mutant forms of p56 ~ were shown to promote in vivo tyrosine phosphorylation ofceUular substrates in p56tck-transfected CHO-CD4 cells as assessed by immunoprecipitation and Western blotting with phosphotyrosinespecific antibodies (data not shown). to CHO-DUKX II (CD4-negative) cells transfected with either wild-type or mutant kinase was equivalent to untransfected controls ( Fig. 2 A, CHO-DUKX-Y505 and CHO-DUKX-F505). Moreover, the binding of Raji to CHO-CD4-Y505 and CHO-CD4-F505 cells was completely inhibited by CD4 and MHC class II-specific mAbs (data not shown).
A trivial explanation for the altered binding of MHC class II + B cells to CHO-CD4-Y505 and CHO-CD4-F505 cells is that expression of p56 ~k resulted in increased levels of CD4 at the cell surface. Indeed, the expression of p56 ~k in nonlymphoid cells inhibits CD4 endocytosis by excluding CD4 from coated pits (32, 33) . However, despite a dramatic increase in adhesion, CHO-CD4-Y505, clone 5, displayed levels of CD4 at the cell surface that were comparable to CHO-CD4 cells, as determined by immunostaining and FACS | analysis (Fig. 4) . Further, reduced adhesion of Raft to CHO-CD4-F505, clone 2, was observed even though this clone displayed more CD4 at the cell surface than CHO-CD4 cells or CHO-CD4-Y505, clone 5 (Fig. 4) . Thus, the altered binding of Raji cells to CHO-CD4-Y505 cells or CHO-CD4-F505 cells was not the result of altered surface expression of CD4 in transfected cells.
Overexpression of src kinases has been demonstrated to cause changes in cell morphology and the expression of the activated form of p56 ~k in NIH 3T3 cells has previously been shown to cause morphologic transformation (13) . We therefore asked whether CHO-CD4-transfected cells were affected by the expression of either form of the lck protein. There were no obvious differences in growth rates, cell size, or shape. Cytoskeletal structure, including microtubule and microfdament organization, was comparable in transfectants (in the absence of Raji B cells) as determined by indirect immunofluorescence microscopy of permeabilized cells (data not shown). Finally, to determine whether expression of any member of the src family of tyrosine kinases in CHO-CD4 cells was sufficient to modify CD4-class II adhesion, we transfected a plasmid encoding the c-src protein into CHO-CD4 cells (Fig. 5 A) . Over-expression of c-src, which does not specifically interact with CD4, did not significantly alter Raji binding (P <0.05).
The Association of CD4 and p56 l~k Is Required for the Regulation of MHC Class II Adhesion. In resting T lymphocytes,
CD4 is stably associated with p56 ~. This intermolecular binding is facilitated by interactions between two pairs of cysteine residues in the amino terminal domain of p56 ~k and in the cytoplasmic domain of CD4. Mutation of any of these cysteines completely abrogates the association of CD4 and p56 t+~ (29, 34, 35) . To examine whether the association between CD4 and p56 ~k is required for the regulation of CD4/MHC class II binding, an alanine was substituted for the cysteine at position 20 in the cDNA(s) encoding both the Y505 and F505 forms of p56 ~k. The mutant constructs (Y505 c^2~ or F505 cam) were then expressed in CHO-CD4 cells and control experiments were performed to demonstrate that the/ck protein could not be immunoprecipitated in association with CD4 (data not shown). Adhesion assays were was decreased as compared with CHO-CD4-Y505 cells; displaying kinetics and magnitude of binding that were similar to CHO-CD4 cells (Fig. 5 A) . By contrast, the binding of Raji to CHO-CD4-F505 c^2~ cells was not significantly different from CHO-CD4-F505 cells (Fig. 5 B) . These data demonstrate that the specific association of wild-type p56 t'k with CD4 is necessary for the rapid time course and augmented binding of MHC class II-expressing B cells.
The Enzymatic Activity of p56 ~k Is Required for Enhanced CD4/Class II Adhesion. To address whether the enzymatic activity of p56 t'k was important for its regulation of CD4/ MHC class II adhesion, a lysine to alanine change was engineered at residue 273 (KA273) which has previously been shown to be essential for the phosphotransferase activity of the protein (36) . CHO-CD4 cells expressing the kinasedeficient form of the protein (CHO-CD4-Y505 KA273) bound fewer Raji cells as compared with CHO-CD4-Y505 cells; both the time course and magnitude of adhesion were decreased (Fig. 6 A) . To confirm further that the tyrosine kinase activity of wild-type p56 ~k was important for augmented CD4/MHC class II adhesion, the binding assay was 1733 Kinch et al.
performed in the presence of genistein; an ATP analogue that specifically binds the catalytic subunit of tyrosine kinases (Fig.  6 B) (37) . The binding of Raji to genistein-treated CHO-CD4-Y505 cells was equivalent to parental CHO-CD4 cells; fewer Raji cells bound genistein-treated CHO-CD4-Y505 cells. Genistein had little or no effect in binding assays using CHO-CD4 cells or CHO-CD4-F505 cells presumably due to the small differences between the number of Raji cells bound to these transfectants at the 4 h time point when binding was measured. Thus, both the constitutively active (p56 ~k F505) as well as inactive forms of the wild-type kinase (p561ckY505 K^273 or genestein-treated CHO-CD4-Y505 cells) fail to augment CD4/MHC class II adhesion. Rather, this appears to be a unique property of wild-type kk protein.
To further analyze the functional requirements of the transfected Ick proteins expressed in CHO-CD4 cells, the tyrosine at position 394 was changed to phenylalanine (YF394) to abrogate the enzymatic activity of Ick. Previous studies have demonstrated that the tyrosine kinase activity of p56 lc~ is positively regulated by a critical tyrosine at residue 394 and mutation of this residue prevents the activation of Ick (17) . Again, mutations which rendered the protein kinase deficient resulted in a loss of phenotype ascribed to the kinaseactive proteins. CHO-CD4-Y505 YF394 cells bound fewer Raji cells as compared with CHO-CD4-Y505 cells (Fig. 6 C) , whereas the binding of Raji to CHO-CD4-F505 YF394 cells was slightly increased as compared to CHO-CD4-F505 cells (Fig. 6 D) . These data are consistent with results obtained with KA273 mutants implying that the YF394 mutation is functionally equivalent to the KA273 mutation in this assay. Moreover, the observed differences in activity between constructs that are wild-type at position 394 and those in which the tyrosine has been changed to phenylalanine (YF394) suggest that p56 l'k can be regulated by phosphorylation at position 394 in CHO cells, consistent with reports that this site is autophosphorylated in vivo. Finally, the levels of the lck kinase in each of the transfectants were analysed by Western blotting using lck-specific antisera (Fig. 7) . All of the transfectants appeared to express similar levels of wild-type or mutant forms of the protein suggesting that differences in adhesion observed with transfectants were not due to variability in the levels of p56 t'~.
CD4-associated Adherens-type Junctions.
A reorganization of CD4 and cytoskeletal elements within the cell membrane of T cells bound to APCs has been previously described by . Thus we sought to determine whether the binding of MHC class II + B cells was associated with an altered distribution of CD4 within the cell membrane of CHO-CD4 cells. For these experiments, monolayers of CHO-CD4 cells were incubated with Raft B cells for 4 h at 37~ to promote optimal adhesion. Inasmuch as the maintenance of stable CD4/MHC class II adhesion is temperature dependent (6), the B cells were removed by incubation at 4~ The monolayers were then fixed, permeabilized, immunostained with OKT4 mAbs, and visualized by indirect immunofluorescence microscopy. By contrast with the diffuse distribution of CD4 on control CHO-CD4 cells that had not encountered MHC class II § B lymphocytes, CD4 was found to be localized in patches at the cell surface after incubation with Raji B lymphocytes (Fig. 8) . A corresponding redistribution of vinculin in CHO-CD4 cells was also detected after the binding of MHC class II-expressing B cells. Similar results were obtained with talin and oe-actinin (data not shown). The selective enrichment and redistribution of cytoskeletal proteins with CD4 at junctional zones likely functions to stabilize CD4/MHC class II-mediated cell adhesion by increasing the local density of CD4 capable of interacting with MHC class II molecules.
p56 l~k Promotes the Association of CD4 with the Cytoskeleton. Interactions between cell surface molecules and the cytoskeleton can regulate the efficiency ofligand binding. For example, the binding of fibroblasts to extracellular matrix components is anchored by interactions between integrin molecules and components of the actin cytoskeleton (41) . A similar accumulation ofcadherins into adherens-typejunctions stabilizes cell-cell interactions (42) . Consequently, pharmacological agents that disrupt the cytoskeleton, such as cytochalasins, also inhibit integrin-and cadherin-mediated adhesion events.
Using similar strategies, we have observed that stable C D 4 / M H C class II adhesion requires an intact cytoskeleton. Pharmacological agents such as cytochalasin D, colchicine, and nocodazole, were shown to disrupt CHO-CD4-Raji B cell conjugates (6) . To further examine how cytoskeletal interactions might regulate C D 4 / M H C class II binding and to determine the role of p56 zck in these interactions, we assessed the physical association of CD4 with the cytoskeleton by measuring whether cell surface CD4 (_+ p56 ~k) was resistant to solubilization with non-ionic detergent. Using this technique, Geppert and Lipsky have previously demonstrated that a fraction ('-20%) of CD4 on peripheral blood T cells is associated with the cytoskeleton (30) . Cytoskeletal association can be evaluated experimentally by staining cell surface proteins with fluorescently labeled mAbs, treating the cells with detergent to remove molecules not associated with the cytoskeleton, and assessing the remaining bound label by flow cytometry. For these experiments, CHO-CD4, CHO-CD4-Y505, and CHO-CD4-FS05 cells were labeled with OKT4-FITC mAb, treated with 1.0% NP-40, and analyzed by flow cytometry (Fig. 9) . Virtually all of the CD4 at the cell surface of CHO-CD4-YS05 cells was resistant to NP-40 treatment thus implying a strong association with detergentinsoluble cytoskeletal components. By contrast, the majority of cell surface CD4 in CHO-CD4 and CHO-CD4-F505 cells was solubilized by detergent treatment and thus not associated with the cytoskeleton. These data indicate that the wild-type, but not the mutant (p5CkF505), form of p56 ~k promotes interactions between CD4 and the cytoskeleton thereby suggesting a mechanism by which p56 ~k might regulate CD4/ MHC class II adhesion via the formation of CD4-associated adherens junctions.
p56 ~k Regulates the Formation of CD4-associated Adherens
Junctions. Previous studies have shown that the level of protein tyrosine kinase activity regulates the formation and stability of focal adhesions. For example, the formation of these structures can be blocked with specific tyrosine kinase inhib-1735 Kinch et al. itors (43) . Elevated protein tyrosine kinase activity can also dissociate integrin-mediatedjunctional interactions (44, 45) . Inasmuch as the level of tyrosine phosphorylation can differentially regulate the formation and stability of such cellular junctions, we sought to determine whether either form of the p56 ~k tyrosine kinase influenced the formation of CD4-associated adherens junctions. After incubation with Raji, the fraction of CHO-CD4 cells displaying aggregated CD4 was measured by indirect immunofluorescence staining with the OKT4 mAb. Adherens junction formation is reported as the fraction of CHO-CD4 cells that display aggregated OKT4 staining (Fig. 10) . In both CHO-CD4 and CHO-CD4-Y505 cells, the formation of adherens junctions preceded detectable binding (compare with Fig. 2 B) . Moreover, CD4 adherens junctions were detected more rapidly in CHO-CD4-Y505 cells than in CHO-CD4 cells; consistent with the enhanced time course and magnitude of Raji adhesion to CHO-CD4-Y505 cells. Further, a greater fraction of CHO-CD4-Y505 cells displayed aggregated CD4 as compared with control CHO-CD4 cells after 4 h of incubation with Raji B cells (Fig. 10) . Adherens junction formation was also analyzed on CHO-CD4 clones expressing the KA273 mutants of p56 ~k (CHO-CD4-Y505 K^273 and CHO-CD4-F505 Kn273 cells). Both the time course and magnitude of CD4 aggregation were decreased with CHO-CD4-Y505 Kn273 cells and more closely resembled the pattern of adherens junction formation seen in CHO-CD4 cells lacking p56 tck (Fig. 10) . Thus, the protein tyrosine kinase activity of wild-type p56 ~k likely increases C D 4 / M H C class II adhesion by augmenting the formation of CD4-associated adherens junctions. We propose that p56 ~ mediates an increased association of CD4 with the cytoskeleton thereby facilitating the formation of adherens junctions, resulting in enhanced cell-cell adhesion.
Strikingly, CD4 aggregation could not be detected on CHO-CD4-F505 cells at any time after the introduction of MHC class II + B cells (Fig. 10) . However, CD4 aggregation was detectable on CHO-CD4 clones expressing the kinase-deficient p56t~kF505 ~273 double mutant (Fig. 10, A) ; suggesting that the enzymatic activity of the F505 mutant p56 ~ prevents CD4 aggregation. Moreover, the inability of CD4 to aggregate on CHO-CD4-FS05 cells correlates with the decreased binding of MHC class II + Raji B cells. In summary, these data strongly argue that elevated tyrosine phosphorylation by p56 kk decreases CD4/MHC class II adhesion by inhibiting the formation of CD4-associated adherens junc- Adherens junction formation was assessed by indirect immunofluorescence staining with FITCconjugated OKT4 mAb. At least 100 CHO cells representing at least 10 different fields of view were counted for each sample and the data is representative of at least three separate experiments.
tions that are required for stable cell-cell adhesion mediated by CD4 and MHC class II molecules.
Discussion
The data presented in this report demonstrate that the expression of a wild-type or constitutively activated form of the p56 ~k protein in CHO-CD4 cells differentially regulates the adhesion of MHC class II + B cells. Both the magnitude and the time course of CD4/MHC class II adhesion are enhanced by the presence of wild-type p56 ~k as compared to cells expressing mutant/ck proteins. The Ick protein likely influences CD4/MHC class II adhesion by effecting a redistribution of CD4, and other cytoskeletal proteins, at the cell surface into adherens-typejunctions at the site of interaction with an MHC class II-expressing cell.
How might wild-type p56 ~k augment CD4/class II adhesion and the formation of adherens junctions? p56 ~k is found associated with the detergent-insoluble fraction in both T cells and transfected fibroblasts (8, 46) , suggesting that p56 ~k may interact directly with cytoskeletal elements. Similarly, we observed that the presence of wild-type p56 ~k renders CD4 resistant to detergent solubilization. We propose that Ick interacts with components of the actin cytoskeleton thus facilitating contacts with CD4 and providing a scaffold onto which adherens junctions can efficiently assemble. Potential targets for this interaction include vinculin, talin, ot-actinin, and paxillin. Indirect immunofluorescence studies reveal that these proteins do, in fact, colocalize with CD4 within adherensjunctions (our manuscript in preparation). While this scaffolding function may provide a mechanism to enhance CD4 adherens junction formation, the nature of the physical linkage is not known at present. One 1736 p56 tck and CD4/MHC Class II Adhesion possibility is that the amino terminus of p56 ~k interacts with CD4 while simultaneously binding one or more cytoskeletal components through its SH2 or SH3 domains (47, 48) . Alternatively, p56 ~k may phosphorylate specific cytosolic proteins which indirectly facilitate interactions between CD4 and the cytoskeleton. A newly discovered family of tyrosinephosphorylated proteins including cortactin and p130, as well as tyrosine kinases such as p125FAK (focal adhesion kinase), may also be involved (49) . The interaction of a T helper cell with an antigen presenting cell results from a number of adhesive interactions including those of LFA-1 with its ICAM ligands, CD2 and LFA-3, and CD4 with MHC class II molecules. Whereas LFA-1/ICAM interactions are responsible for initial adhesion events, CD4-class II adhesive interactions are only detected after 2 h (this report and references 6 and 50), implying that CD4/class II binding is probably not involved in the initial formation of T ceI1/APC conjugates. The inability to detect CD4/MHC class II adhesion at these earlier times likely reflects the time required for the mobilization of CD4 into adherens-type junctions. The selective enrichment of CD4 at junctional zones likely stabilizes cell adhesion by increasing the overall avidity of its interaction with MHC class II molecules and may be important for the longterm maintenance of stable T cell adhesion. This is supported by our observation that cell adhesion mediated by CD4 and class II is a stable, long-lived interaction that may be essential to the function of the T helper cell, i.e., lymphokine secretion, and is in contrast with the rapid and transient interaction of cytolytic T cells with their targets (51) .
The T cell receptor, LFA-1 and components of the microtubule organizing center colocalize with CD4 in the cell membrane of T helper cells, oriented towards the site of interaction with an MHC class II + B lymphocyte (38--40, 51) . The reorganization of cellular components correlates with antigenspecific recognition and is not detected in T cells bound to B cells expressing irrelevant antigen (39) . LFA-/ICAM binding was recognized as the predominant adhesive interaction stabilizing T/B conjugates, and it was proposed that a redistribution of LFA-1 might facilitate TCR capping at the cell/cell junction (52) . As CD4 did not aggregate in the absence of LFA-l-mediated adhesion, it was presumed that the transcellular bond between CD4 and MHC class II was too weak to cause CD4 aggregation. Rather, interactions between TCR and CD4 were thought to selectively enhance CD4 accumulation at the T cell/APC junction; thereby increasing the avidity of the weak binding of CD4 to MHC class II. Thus, CD4 could only interact with MHC class II ligands once sequestered within the cell contact region. Recent observations by our laboratory do not concur with this view of CD4 function. Substantial CD4 adhesion and redistribution within the membrane can be detected in the absence of TCR or LFA-1 molecules using this adhesion assay (this report and reference 6). Moreover, there is increasing evidence that the CD4-MHC class II interaction is of sufficient avidity to contribute to T cell adhesion inasmuch as conjugates with B lymphocytes can be disrupted by CD4-specific mAbs (50, 53; and our unpublished observations). Our data support a model in which 1737 Kinch et al. the molecular interaction of CD4 with MHC class II proteins facilitates cell adhesion by inducing the reorganization of CD4 (and perhaps the TCR and cytosolic components) at sites of cell/cell contact.
How might this active reorganization of CD4 and cytoskeletal proteins into adherens type junctions influence T cell function in vivo? CD4 adherens junctions might stabilize cellular interactions at times when other adhesive interactions are no longer operative. This notion is supported by recent studies documenting the transient nature of LFA-l-mediated adhesions (54) and cascades ofT cell adhesions (55) . The formation of CD4 adherens junctions might also define the area of surface contact between a T lymphocyte and specific APC. Using alloantigen immobilized onto variably sized latex beads, Mescher determined that a minimum cell diameter of 4-5 #m is necessary for the productive recognition of presented antigen (56) . The diameter of a CD4-associated adherens type junction encompasses a diameter of at least 6 #m on CHO-CD4 cells (our unpublished data), suggesting that the cell contact region defined by this structure is within the range defined for productive T cell interactions. The aggregation of CD4 might directly influence T cell signal transduction by aggregating p56 ~k molecules at the intercellular junction. Clustering of p56 ~k is known to induce its enzymatic activities (8), potentially via autophosphorylation and the assembly of CD4 adherens junctions might provide a mechanism for the induction of tyrosine phosphorylation. Finally, biophysical measurements of receptor/ligand interactions reveal that ligand binding can facilitate cell signaling by increasing the duration of receptor aggregation (57) . Consequently, CD4 adherensjunctions might enhance T cell signaling by increasing the length of time in which CD4 and TCR bind their common ligand, the MHC class II molecule.
Straus and Weiss have previously demonstrated that p56 ~ is essential for T cell activation and IL-2 production using the JCAM-1 cell line which lacks the tck protein (58) . Similarly, we demonstrate that mutants of the kk protein lacking kinase activity fail to support enhanced CD4/class II-mediated cell adhesion. These data appear to conflict with several recent reports which argue that the kinase function of p56/ck is not essential for its ability to enhance the responsiveness of a class II-reactive hybridoma (36, 59 ). However, in both studies, kinase-deficient Ick proteins were expressed in parent cells which contained wild-type protein. Moreover, those studies were designed to measure T cell responsiveness and the kinase activity of the kk protein may be dispensable for the enhanced responsiveness of a T cell hybridoma. By contrast, we are solely measuring CD4-class II adhesion and our data demonstrate that the kinase activity of p56 ~ is essential for enhanced cell adhesion. Inasmuch as the importance of CD4-class II adhesion has remained somewhat controversial, a direct demonstration of the regulation of CD4-mediated cell adhesion by an associated protein tyrosine kinase provides new insight into the function(s) of both CD4 and p56 ~k. Moreover, these results have general implications for the regulation of cell adhesion by tyrosine kinases and suggest that specific elements of the cytoskeleton may act as substrates for this family of protein tyrosine kinases.
Finally, the experiments presented in this report demonstrate that the constitutively elevated tyrosine kinase activity by p56 ~k decreases the efficiency of CD4/MHC class II adhesion and prevents the clustering of CD4 at sites of cell-cell interaction. Enhanced levels of tyrosine phosphorylation of cellular substrates are observed in the presence of the F505 form of the kinase although we have not as yet identified these proteins. Elevated tyrosine kinase activity has previously been found to disrupt the aggregation of various integrin and cadherin adhesion molecules; thereby decreasing ceil/substratum and cell/cell binding (44, 45) . If a similar redistribution of the cytoskeleton is necessary for the maintenance of stable T cell/APC conjugates, elevated kinase activity could transduce a signal for de-adhesion. This is currently under investigation in our laboratory. 
